Publication | Closed Access

Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin–Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity

NanomedicineDrug TargetingEngineeringAttenuated Hemolysis ToxicityMedicinePolymer-drug ConjugateEnhanced Antitumor TherapyPharmacologyTherapeutic NanomaterialsDrug Delivery SystemsNano-drug DeliveryTumor TargetingBiomedical EngineeringOncologyTumor BiologyTumor-targeted Delivery